А. М. Chomakhidze

Efficacy and Safety of Adalimumab Long-Term Administration with Immunosuppressants at Juvenile Idiopathic Arthritis without Systemic Manifestations

E. Alexeeva, T. Sleptsova, S. Valieva, 2016 .